$AZ

A2Z Reports Second Quarter 2026 Revenue of $5.9 Million

A2Z Cust2Mate Solutions Corp. (NASDAQ: AZ) reported Q2 2026 revenue of $5.9 million, up from $1.2 million, with Smart Cart revenue of $4.41 million. Gross profit rose to $2.5 million and gross margin to 42.6%. Net loss was $7.3 million. The company cited a $30 million credit line with Bank Leumi and expects $25 million in H2 smart cart revenue.

Original reporting
Published Aug 12, 2026, 8:45 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 12, 2026, 9:38 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$AZ
Bullish
medium confidence
Mentioned
$AZ
Relevance
8/10
alphai data visualization · based on prnewswire.com
Decision brief

The 30-second read

$AZBullishMed
01

Why it matters

Traders can reassess near-term revenue trajectory and financing runway based on the reported scale-up (950 units in Q2), margin expansion (42.6% gross margin), and quantified H2 smart-cart revenue projection ($25M).

02

Market read

Q2 earnings and forward-looking H2 revenue guidance, plus a new credit line and manufacturing ramp, are the core catalysts for AZ positioning.

03

What to watch

The company targets 10,000 carts by year-end and cites backlog visibility, but the release does not quantify backlog value, customer contract terms, or gross margin sustainability assumptions.

Relevance 8/10Novelty 8/10Timing: after-hours today, ahead of the 5 PM ET conference call

Background

A2Z Cust2Mate Solutions sells Smart Cart connected retail technology; this release covers Q2 results, customer deliveries, manufacturing capacity, financing, and cost actions.

Company-level read

Ticker impact

$AZBullishMedium confidence
Context

A2Z reported Q2 2026 revenue of $5.9M, gross margin 42.6%, and a $30M Bank Leumi credit line, plus H2 $25M smart-cart revenue guidance.

Expected impact

Near-term upside bias as traders price in improved unit economics and the $25M H2 smart-cart revenue projection, tempered by continued large net losses.

Evidence & confidence

The release contains multiple concrete, decision-relevant datapoints: revenue and margin expansion, operating expense reduction plan, credit line, and quantified H2 revenue expectations. However, profitability remains negative (net loss $7.3M), and the guidance is still forward-looking.

Market effects

Highlights potential demand for connected in-store retail tech and retail media monetization, but does not provide broader sector data.

Israel-focused customer wins and manufacturing ramp may draw attention to regional retail-tech supply chains.

Mentions expansion opportunities to Europe and the Americas, but without specific counterparties or contracts beyond Israel.

Counterpoint

Margin improvement may be partly mix and ramp-driven; if delivery acceleration slips, the H2 $25M smart-cart revenue weighting to Q4 could disappoint.

Key entities

  • A2Z Cust2Mate Solutions Corp.

    NASDAQ-listed smart retail technology provider reporting Q2 2026 results and H2 2026 revenue expectations.

  • Bank Leumi

    Lender for a $30 million credit line initiated/closed in Q2 2026.

  • HaStock

    New supermarket customer in Israel, took delivery of roughly half of 2,000 contracted units in Q2.

  • Super Sapir

    Israeli food retailer that placed an increased order for 4,000 additional units.

  • Gadi Graus

    CEO quoted on execution, platform launch, financing, and cost management initiatives.

Related articles

$AZMedAI 8/10

Allianz enters deal to acquire UOB asset management arm

Allianz Global Investors agreed to acquire UOB Asset Management for S$555m (US$432.7m), covering UOBAM operations in eight Asian markets. UOB and AGI will also form a distribution partnership. UOB expects a pre-tax gain of about S$330m and a CET ratio lift of 14 bps, subject to regulatory approval, with closing in 2027.

$AZMedAI 8/10

Pathos AI signs two cancer deals with Alphamab and AZ

Pathos AI said it licensed Alphamab’s bispecific ADC JSKN016 for solid tumors outside Greater China in a deal worth up to $2.2 billion, including $125 million upfront, up to $2.09 billion in milestones and royalties. JSKN016 targets TROP2 and HER3 and is in Phase 3 for TNBC. Pathos also partnered with AstraZeneca on AZD4241, an ER-targeting PROTAC in preclinical testing for HR-positive, HER2-negative breast cancer.

$AZMed

Allianz Asia Holding Pte. Ltd. agreed to acquire HSBC Life Pte. Ltd. from HSBC Holdings plc for SGD 2.7 billion.

Allianz Asia Holding Pte. Ltd. agreed to acquire HSBC Life (Singapore) Pte. Ltd. from HSBC Holdings plc for SGD 2.7 billion, including SGD 2.7 billion allocated to HSBC Life’s common equity. The deal is subject to regulatory approval, with expected completion between Jan 1 and Jun 30, 2027. HSBC Life reported EBIT of SGD 118.1 million for 2025.